A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
Clinical trial NCT07040228 · RECRUITING
Trial details
- NCT number
- NCT07040228
- Sponsor
- Junjie Hang
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-26
- Primary completion
- 2027-05-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.